Timothy M Hughes, Jordan Tanley, Haiying Chen, Christopher L Schaich, Joseph Yeboah, Mark A Espeland, Joao A C Lima, Bharath Ambale-Venkatesh, Erin D Michos, Jingzhong Ding, Kathleen Hayden, Ramon Casanova, Suzanne Craft, Stephen R Rapp, José A Luchsinger, Annette L Fitzpatrick, Susan R Heckbert, Wendy S Post, Gregory L Burke
BACKGROUND AND AIMS: Subclinical cardiovascular disease (CVD) measures may reflect biological pathways that contribute to increased risk for coronary heart disease (CHD) events, stroke, and dementia beyond conventional risk scores. METHODS: The Multi-Ethnic Study of Atherosclerosis (MESA) followed 6814 participants (45-84 years of age) from baseline in 2000-2002 to 2018 over 6 clinical examinations and annual follow-up interviews. MESA baseline subclinical CVD procedures included: seated and supineblood pressure, coronary calcium scan, radial artery tonometry, and carotid ultrasound...
March 15, 2024: Atherosclerosis